Portola Pharmaceuticals, Inc.


Our goal is to build an enduring biopharmaceutical company with a foundation of products and product candidates that significantly advance patient care in the areas of thrombosis, other hematologic disorders and inflammation.

We are advancing our three compounds using novel biomarker and genetic approaches that may increase the likelihood of clinical, regulatory and commercial success of our potentially life-saving therapies



270 E. Grand Avenue
San Francisco, California 94080
United States

Get Directions

Upgrade Your Listing